Published on:
December 20, 2022
Among young adults, 2-year crab endurance accrued much successful states with expanded Medicaid coverage; immoderate pharmacies implemented acquisition limits to assistance combat children’s medicine proviso shortages; an FDA advisory sheet volition conscionable adjacent period to sermon the authorities of the COVID-19 pandemic.
Expanded Medicaid Coverage Linked to Better Cancer Survival Among Young Adults
According to probe published successful the Journal of Clinical Oncology, expanded Medicaid sum nether the Affordable Care Act is linked to amended endurance outcomes for young adults with recently diagnosed cancer, The Hill reported. The survey besides recovered the 2-year endurance payment was astir notable among Hispanic and Black individuals, and individuals with bosom crab oregon signifier IV cancers. Among young adults, 2-year wide endurance accrued much successful states with expanded Medicaid coverage, with endurance rising from 90.39% to 91.85% aft the enlargement successful these states. According to the survey authors, young Americans person historically not experienced the aforesaid endurance improvements implicit clip compared with pediatric and older patients, mostly owed to deficiency of wellness insurance.
Early Flu Season Creates Children’s OTC Medicine Shortage
As flu play began earlier than accustomed this year, shortages of children’s acetaminophen (Tylenol), amoxicillin, and different OTC medicines person led to acquisition limits astatine immoderate pharmacies, the Associated Press reported. According to experts, these shortages—which alteration by location—are mostly owed to the higher fig of children who are sick during this clip of twelvemonth and whitethorn proceed done the wintertime season, but should not past arsenic agelong arsenic caller babe look and medicine cause shortages. Because these OTC medicine shortages are occurring astatine the purchasing level and not the manufacturing level, pediatricians counsel to look for alternate oregon generic versions of products and to cheque different stores.
FDA Panel to Discuss Future of COVID-19 Vaccines
An FDA advisory sheet volition conscionable January 26, 2023, to sermon the authorities of the COVID-19 pandemic, including whether vaccines request to beryllium further modified to support up with caller variants and different changes, Axios reported. The past gathering of this benignant was held successful June 2022, erstwhile advisers recommended updated COVID-19 boosters targeting the Omicron variant. Following this meeting, the FDA volition see whether to urge adjusting existent vaccine authorizations, arsenic good arsenic the astir businesslike process to take strains to see successful superior and booster vaccine doses.
English (US)